IL2 and neoplasm: Autologous fibroblasts transduced with IL-2 and mixed with autologous irradiated tumour cells have been used in phase I trials to treat colorectal carcinoma (Sobol et al, 1999), and IL-12-transduced autologous fibroblasts have been used to treat melanoma (Kang et al, 2001), both with promising results.